Back to top Open menu arrow
Download Reprints
The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry
Access icon

Letter to the Editor March 31, 1999

Bupropion Clarification

Richard S. Kent

J Clin Psychiatry 1999;60(3):196

Article Abstract

Letter to the Editor

Sir: The recent Glaxo Wellcome-sponsored supplement to the Journal entitled "Beyond SSRIs" provides clinicians with useful information regarding the treatment of depression and discusses our bupropion product. I would like to provide clarification on some aspects of the supplement relating to bupropion.

 

Download Free PDF

Save Save

Share Share

Cite Cite

Vol 85 • 2024 • Number 3

Read the Current Issue

Editorial

Focus on Women’s Mental Health: Twenty Years and Counting

Original Research

Esmethadone in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants

Commentary

Can Our Collective Experiences As Clinicians Improve Mental Health Care?

Original Research

Prescription Opioid Use Disorder in US Adults Reporting Prescription Opioid Use

Original Research

Symptomatic Disorders Comorbid with Borderline Personality Disorder Over Time

Original Research

Aripiprazole Lauroxil Initiation Regimens
View current Issue

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe